TrialNature medicine2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.
David Erritzoe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it